BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18188593)

  • 1. Clinical significance of nuclear factor (NF)-kappaB levels in urothelial carcinoma of the urinary bladder.
    Levidou G; Saetta AA; Korkolopoulou P; Papanastasiou P; Gioti K; Pavlopoulos P; Diamantopoulou K; Thomas-Tsagli E; Xiromeritis K; Patsouris E
    Virchows Arch; 2008 Mar; 452(3):295-304. PubMed ID: 18188593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C-α (PKCα) modulates cell apoptosis by stimulating nuclear translocation of NF-kappa-B p65 in urothelial cell carcinoma of the bladder.
    Zheng J; Kong C; Yang X; Cui X; Lin X; Zhang Z
    BMC Cancer; 2017 Jun; 17(1):432. PubMed ID: 28629334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of replication protein A (RPA) expression levels in bladder urothelial carcinoma.
    Levidou G; Gakiopoulou H; Kavantzas N; Saetta AA; Karlou M; Pavlopoulos P; Thymara I; Diamantopoulou K; Patsouris E; Korkolopoulou P
    BJU Int; 2011 Jul; 108(2 Pt 2):E59-65. PubMed ID: 21062395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis.
    Weichert W; Boehm M; Gekeler V; Bahra M; Langrehr J; Neuhaus P; Denkert C; Imre G; Weller C; Hofmann HP; Niesporek S; Jacob J; Dietel M; Scheidereit C; Kristiansen G
    Br J Cancer; 2007 Aug; 97(4):523-30. PubMed ID: 17622249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
    Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
    Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of NF-kappa B in human bladder cancer and its clinical significance].
    Xie DH; Tang XD; Xia SJ; Tan JM; Wang XH; Cai Y
    Ai Zheng; 2002 Jun; 21(6):663-7. PubMed ID: 12452071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder.
    Yin W; Chen N; Zhang Y; Zeng H; Chen X; He Y; Wang X; Zhou Q
    Mod Pathol; 2006 Nov; 19(11):1487-97. PubMed ID: 16892011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling.
    Inoue S; Ide H; Mizushima T; Jiang G; Netto GJ; Gotoh M; Miyamoto H
    Mol Cancer Ther; 2018 Jun; 17(6):1303-1314. PubMed ID: 29592878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.
    Korkolopoulou P; Goudopoulou A; Voutsinas G; Thomas-Tsagli E; Kapralos P; Patsouris E; Saetta AA
    Urology; 2004 Jun; 63(6):1198-204. PubMed ID: 15183989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAIL and osteoprotegerin (OPG) expression in bladder urothelial carcinoma: correlation with clinicopathological parameters and prognosis.
    Levidou G; Thymara I; Saetta AA; Papanastasiou P; Pavlopoulos P; Sakellariou S; Fragkou P; Patsouris E; Korkolopoulou P
    Pathology; 2013 Feb; 45(2):138-44. PubMed ID: 23277172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of classical NF-kappaB pathway effectors in human ovarian carcinoma.
    Darb-Esfahani S; Sinn BV; Weichert W; Budczies J; Lehmann A; Noske A; Buckendahl AC; Müller BM; Sehouli J; Koensgen D; Györffy B; Dietel M; Denkert C
    Histopathology; 2010 May; 56(6):727-39. PubMed ID: 20546338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression.
    Shukla S; MacLennan GT; Fu P; Patel J; Marengo SR; Resnick MI; Gupta S
    Neoplasia; 2004; 6(4):390-400. PubMed ID: 15256061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
    Chang WC; Chang YH; Pan CC
    Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of nuclear factor kappaB in human gastric carcinoma: relationship with I kappaB a and prognostic significance.
    Levidou G; Korkolopoulou P; Nikiteas N; Tzanakis N; Thymara I; Saetta AA; Tsigris C; Rallis G; Vlasis K; Patsouris E
    Virchows Arch; 2007 May; 450(5):519-27. PubMed ID: 17429689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor-kappaB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma.
    Gallel P; Pallares J; Dolcet X; Llobet D; Eritja N; Santacana M; Yeramian A; Palomar-Asenjo V; Lagarda H; Mauricio D; Encinas M; Matias-Guiu X
    Hum Pathol; 2008 Jul; 39(7):994-1001. PubMed ID: 18508109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear E-cadherin expression is associated with the loss of membranous E-cadherin, plasmacytoid differentiation and reduced overall survival in urothelial carcinoma of the bladder.
    Keck B; Wach S; Kunath F; Bertz S; Taubert H; Lehmann J; Stöckle M; Wullich B; Hartmann A
    Ann Surg Oncol; 2013 Jul; 20(7):2440-5. PubMed ID: 23108554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1.
    Rausch S; Hennenlotter J; Teepe K; Kuehs U; Aufderklamm S; Bier S; Mischinger J; Gakis G; Stenzl A; Schwentner C; Todenhöfer T
    Urol Oncol; 2015 Oct; 33(10):426.e21-9. PubMed ID: 26231311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine-1-phosphate receptor 1 (S1PR1) expression in non-muscle invasive urothelial carcinoma: Association with poor clinical outcome and potential therapeutic target.
    Go H; Kim PJ; Jeon YK; Cho YM; Kim K; Park BH; Ku JY
    Eur J Cancer; 2015 Sep; 51(14):1937-45. PubMed ID: 26238015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistochemical analysis of nuclear factor, p38, and cyclin D1 proteins in premalignant lesions and carcinomas of the colorectal mucosa].
    Lee SD
    Korean J Gastroenterol; 2008 Dec; 52(6):359-67. PubMed ID: 19096253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.